{
    "title": "114_hr2391",
    "content": "The Act titled \"Medicaid Generic Drug Price Fairness Act of 2015\" applies the Medicaid additional rebate requirement to generic drugs. The Medicaid Generic Drug Price Fairness Act of 2015 applies additional rebate requirements to generic drugs under Section 1927(c)(3) of the Social Security Act. The rebate amount for non-single source or innovator multiple source drugs is increased in a similar manner to single source or innovator multiple source drugs, with some exceptions. The Medicaid Generic Drug Price Fairness Act of 2015 increases rebate requirements for generic drugs. The strength of single source or innovator multiple source drugs is increased under certain conditions, with special rules for application. The Medicaid Generic Drug Price Fairness Act of 2015 increases rebate requirements for generic drugs, with special rules for application. References to specific calendar quarters and dates are adjusted to reflect the lowest average manufacturer price for the drug during a specified period. The Medicaid Generic Drug Price Fairness Act of 2015 adjusts references in subparagraphs for specific dates and drug classifications, with special rules for noninnovator multiple source drugs. The Medicaid Generic Drug Price Fairness Act of 2015 includes special rules for noninnovator multiple source drugs, adjusting references for specific dates and drug classifications. The Medicaid Generic Drug Price Fairness Act of 2015 includes rules for noninnovator multiple source drugs, with amendments applying to rebate periods after December 31, 2014."
}